Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
1 other identifier
observational
28,813
1 country
6
Brief Summary
Since 2009, a programmatic community-based strategy (COPE) has been implemented to address health disparities among Navajo individuals living with multiple chronic conditions. COPE (Community Outreach and Patient Empowerment) targets individual, family, and health system-level factors through four activities: 1) coordination between community health representatives (CHRs) and Indian Health Service providers; 2) CHR competency with standardized training; 3) a culturally-sensitive health promotion curriculum for patients and families; and 4) strong CHR supervision. COPE has been implemented throughout Navajo Nation. Enrollment is programmatic; in other words, the decision to enroll a patient in COPE occurs independently of whether the patient is in this study. Participants receive the COPE intervention in the same manner and intensity, whether they are included in this observational study or not. The main goal of this observational research is to understand if COPE improves the lives of participating community members. The Primary Aim is to assess the impact of the COPE Project on changes in HbA1c and other CVD risk factors. Hypothesis: Patients enrolled in the COPE program will experience a reduction in HbA1c compared to the control group. Secondary aims are: 1) To understand if COPE improves patients' own self-reported outcomes. Hypothesis: COPE patients will report better health compared with their own baseline at 12 months. 2) To Identify factors associated with increased effectiveness of the COPE Project at the individual, community, and health system level using a mixed-model approach. 3) To understand diverse stakeholder perspectives on COPE impact and value among CHRs, providers and the health care system. Hypothesis: Compared with baseline, CHRs will report greater empowerment in their work, providers will report greater confidence in CHRs. The observational cohort will be comprised of individuals with diabetes receiving care at one of the participating health facilities. Cases include individuals participating in the COPE intervention; controls are non-COPE participants identified within the same hospital and matched based on similar baseline characteristics. Study findings will improve clinical and patient-decision making and the health of marginalized AI/ANs by informing policies to promote CHR interventions in rural and underserved communities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Typical duration for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2015
CompletedFirst Submitted
Initial submission to the registry
October 24, 2017
CompletedFirst Posted
Study publicly available on registry
October 31, 2017
CompletedResults Posted
Study results publicly available
December 16, 2025
CompletedMay 27, 2026
May 1, 2026
2.2 years
October 24, 2017
November 20, 2017
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Percentage of Glycated Hemoglobin (HbA1c)
Change in Hemoglobin A1c measured at 24 months, compared with baseline
24 months
Secondary Outcomes (13)
Change in Systolic Blood Pressure
24 months
Change in Low-density Lipoprotein
24 months
Change in Body Mass Index
24 months
Change in Primary Outpatient Services
24 months
Change in Specialty Outpatient Services
24 months
- +8 more secondary outcomes
Other Outcomes (3)
Patient-reported Good Health
12 months
Patient-reported Sense of Control
12 months
Patient-reported Ability to Cope
12 months
Study Arms (2)
COPE participants
Individuals living with diabetes seen at a study site who were enrolled in the COPE programmatic intervention during the study period. Participation in COPE consists of receiving home visits by a Navajo Community Health Representative (CHR) once or twice a month for a period of at least 12 months. CHRs use structured patient coaching materials to support behavior change. CHRs also check vital signs, monitor blood glucose levels through finger sticks, and facilitate access to appointments and medical refills. CHRs communicate regularly with providers through electronic health record documentation and case management rounds. In-person or telephone communication is be used to address acute issues that may arise.
Non-COPE participants
Individuals living with diabetes seen at a study site, did not participate in the COPE programmatic intervention, and had comparable baseline characteristics.
Eligibility Criteria
Individuals receiving care at a Navajo Area Indian Health Service facility, living with diabetes
You may qualify if:
- Diagnosis of diabetes
- Treated at a participating IHS facility corresponding to their home residence
You may not qualify if:
- Not seen in one of the six participating clinical sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Eastern Research Groupcollaborator
Study Sites (6)
Chinle Comprehensive Health Care Facility
Chinle, Arizona, 86503, United States
Tsehootsooi Medical Center
Fort Defiance, Arizona, 86504, United States
Kayenta Health Center
Kayenta, Arizona, 86033, United States
Crownpoint Health Center Facility
Crownpoint, New Mexico, 87313, United States
Gallup Indian Medical Center
Gallup, New Mexico, 87301, United States
Northern Navajo Medical Center
Shiprock, New Mexico, 87420, United States
Related Publications (4)
Franz C, Atwood S, Orav EJ, Curley C, Brown C, Trevisi L, Nelson AK, Begay MG, Shin S. Community-based outreach associated with increased health utilization among Navajo individuals living with diabetes: a matched cohort study. BMC Health Serv Res. 2020 May 25;20(1):460. doi: 10.1186/s12913-020-05231-4.
PMID: 32450874DERIVEDBrown C, Lalla A, Curley C, King C, Muskett O, Salt S, Ray K, Begay MG, Nelson AK, Shin S. Community-clinic linkages: qualitative provider perspectives on partnering with community health representatives in Navajo Nation. BMJ Open. 2020 Feb 12;10(2):e031794. doi: 10.1136/bmjopen-2019-031794.
PMID: 32054623DERIVEDLalla A, Salt S, Schrier E, Brown C, Curley C, Muskett O, Begay MG, Shirley L, Clark C, Singer J, Shin S, Nelson AK. Qualitative evaluation of a community health representative program on patient experiences in Navajo Nation. BMC Health Serv Res. 2020 Jan 8;20(1):24. doi: 10.1186/s12913-019-4839-x.
PMID: 31914997DERIVEDTrevisi L, Orav JE, Atwood S, Brown C, Curley C, King C, Muskett O, Sehn H, Nelson KA, Begay MG, Shin SS. Integrating community health representatives with health care systems: clinical outcomes among individuals with diabetes in Navajo Nation. Int J Equity Health. 2019 Nov 27;18(1):183. doi: 10.1186/s12939-019-1097-9.
PMID: 31771603DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This is an observational study using routine clinical data for endpoints other than patient-reported outcomes. Therefore, the participant flow and adverse event reporting did not conform to clinical trial protocols. For patient-reported outcomes, we used mixed methods (including pre-post surveys among a sub-set of COPE participants and qualitative interviews) but did not collect or compare data from a control arm.
Results Point of Contact
- Title
- Dr. Sonya Shin
- Organization
- Brigham and Women's Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Sonya S Shin, MD MPH
Brigham and Women's Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Physician
Study Record Dates
First Submitted
October 24, 2017
First Posted
October 31, 2017
Study Start
November 1, 2013
Primary Completion
December 31, 2015
Study Completion
December 31, 2015
Last Updated
May 27, 2026
Results First Posted
December 16, 2025
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share